Interestingly, we also observed a greater selection of NFKBIE-mutated murine leukemia cells in immunocompetent compared to immunodeficient mice, suggesting that the presence of NFKBIE mutations may impact the anti-tumor immune response. This evidence concerns the gene NFKBIE and leukemia.